Evidence map›Paper›PMID 32725226›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Assessing the Feasibility of Typhoid Elimination.

Jeffrey D Stanaway, Phionah L Atuhebwe, Stephen P Luby, John A Crump

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Typhoid fever.Nature reviews. Disease primers · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Spatial and Genomic Data to Characterize Endemic Typhoid Transmission.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  10. UnderstandingCells · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Jeffrey D StanawayInstitute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.
Phionah L AtuhebweWorld Health Organization, Regional Office for Africa, Brazzaville, Congo.
Stephen P LubyInfectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA.
John A CrumpCentre for International Health, University of Otago, Dunedin, New Zealand.
Institute for Health Metrics and Evaluation · USStanford University · USUniversity of Otago · NZWorld Health Organization Regional Office for Africa · CG

Funding

World Health Organization 001
6 · The paper itself

Abstract

In 1993, the International Task Force on Disease Eradication classified the political will for typhoid eradication as "none." Here we revisit the Task Force's assessment in light of developments in typhoid vaccines and increasing antimicrobial resistance in Salmonella Typhi that have served to increase interest in typhoid elimination. Considering the requisite biological and technical factors for elimination, effective interventions exist for typhoid, and humans are the organism's only known reservoir. Improvements in water supply, sanitation, hygiene, and food safety are critical for robust long-term typhoid control, and the recent Strategic Advisory Group of Experts on Immunization recommendation and World Health Organization prequalification should make typhoid conjugate vaccine more accessible and affordable in low-income countries, which will allow the vaccine to offer a critical bridge to quickly reduce burden. While these developments are encouraging, all current typhoid diagnostics are inadequate, having either poor performance characteristics, limited scalability, or both. No clear solution exists, and this should be viewed as a critical challenge to any elimination effort. Moreover, asymptomatic carriers and limited data and surveillance remain major challenges, and countries considering elimination campaigns will need to develop strategies to identify high-risk populations and to monitor progress over time. Finally, policymakers must be realistic in planning, learn from the planning failures of previous elimination and eradication efforts, and expect unforeseeable shocks and setbacks. In the end, if we assume neither unanticipated breakthroughs in typhoid control nor any chaotic shocks, history suggests that we should expect typhoid elimination to take decades.

Indexed as

Typhoid FeverTyphoid-Paratyphoid VaccinesFeasibility StudiesHumansSalmonella typhiWorld Health OrganizationTyphoid-Paratyphoid VaccinescontroleliminationSalmonella Typhityphoidvaccine

Identifiers

PMID32725226
PMCPMC7388713
OpenAlexW3046718773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.